Company news
Marinomed Biotech Ag (VIE:MARI) news
Marinomed Biotech Ag news releases on 6ix. Latest, Jul 22, 2026: Ad-hoc: Marinomed Biotech AG files for court restructuring proceedings without…
Press releases & updates
Ad-hoc: Marinomed Biotech AG files for court restructuring proceedings without self-administration
July 22, 2026
Ad-hoc: Marinomed Biotech AG plans to apply for court restructuring proceedings without self-administration
July 16, 2026
Marinomed Biotech AG: Release according to Article 135, Section 2 BörseG with the objective of Europe-wide distribution
June 29, 2026
Marinomed Biotech : Statement pursuant to § 87 Abs.2 AktG - Thomas Stümmler ( 87 declaration Thomas Stuemmler E)
May 21, 2026
Marinomed Biotech : Form for proxy to IVA (2026 Vollmacht IVA EN FINAL)
May 20, 2026
Marinomed Biotech AG Announces Strategic Partnership and Worldwide Licensing for Marinosolv® Technology in Inhalation Therapy
May 19, 2026
Marinomed Biotech AG announces progress with Tacrolimus Eyedrops for Entry into the Compounding Market
May 11, 2026
Marinomed Announces Strategic Expansion into Compounding Services Featuring Marinosolv® Technology
April 22, 2026
Marinomed Biotech AG: Release of a Financial report
April 22, 2026
Marinomed secures financing through successful capital increase
April 13, 2026